Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > GUD trading at fair value?
View:
Post by EbbFlow88 on Jan 12, 2021 3:22pm

GUD trading at fair value?

I did some back of the napkin calculations and noticed that GUD is pretty fairly valued as of today and that seems to be 100% related to the BRL currency.

The cash and cash equivalents total approx. $3/share leaving $2.40/share today for GBT.

If you take todays exchange rate of CAD/BRL, it is 25% lower since the date of acquisition of GBT.

GBT acquired for $389M x 75% = $292M which is roughly $2.25 per share.


So, the market isn't necessarily punishing Goodman based off this move but he has certainly lost his Goodman premium.

Assuming there is another acquisition in the pipeline which can diversify the currency risk, that may reflate his premium. Then there is upside of the growth of this business which I believe he will execute on.

Seems to be pretty cheap here based off future growth potential unless BRL is going to get hammered more. For long term investors, this is a great entry point in my opinion.
Comment by Benedict16th on Jan 12, 2021 3:30pm
Thanks for the insight, in all brilliant black Knight’s strategist lost 100 million dollar  on the GBT deal and no profits nor new drugs so far. Anyone applauding the GUD team? 
Comment by EbbFlow88 on Jan 12, 2021 3:55pm
I guess that depends on what you think the future is for the BRL.It is historically cheap now. Will that continue or revert to the mean? If you believe that GUD bought it cheap, well now its very cheap.  If you have a long-term view, then it is likely it will rebound, GBT will grow and GUD will make more acquisitions. Maybe I'm wrong but odds seem in our favor here.
Comment by wagyusteak on Jan 12, 2021 7:10pm
  you can't explain reasons to a knucklehead bro. We tried, it didn't work. Just talk stock price to him. He understands it. Up means good, down means bad. Lol
Comment by MrMugsy on Jan 13, 2021 2:14am
I agree with you EbbFlow ... we're at a buyer's price. That's exactly what we're doing at these levels !!! If the BRL gets hammered some more, that just makes LATAM assets potentially more interesting to Goodman. IMO.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities